America August 27, 2024
UCB’s $680M Chinese Portfolio Sale to Investment Firms
Belgian biopharmaceutical company UCB has announced plans to sell its $680 million Chinese portfolio to investment firms based in Singapore…
America August 27, 2024
Belgian biopharmaceutical company UCB has announced plans to sell its $680 million Chinese portfolio to investment firms based in Singapore…
By Rihem Akkouche